[{"id":"42184972-51da-43bd-9ec8-a23368735f3a","acronym":"","url":"https://clinicaltrials.gov/study/NCT00503568","created_at":"2021-01-29T06:57:15.823Z","updated_at":"2024-07-02T16:37:27.050Z","phase":"Phase 1","brief_title":"Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy","source_id_and_acronym":"NCT00503568","lead_sponsor":"University of Miami","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e viagenpumatucel-L (HS-110) • gp96-Ig vaccine"],"overall_status":"Completed","enrollment":" Enrollment 19","initiation":"Initiation: 05/01/2007","start_date":" 05/01/2007","primary_txt":" Primary completion: 08/01/2012","primary_completion_date":" 08/01/2012","study_txt":" Completion: 08/01/2012","study_completion_date":" 08/01/2012","last_update_posted":"2016-12-15"}]